•  
News
  1. Healio
  2. Hematology/Oncology

Hematology/Oncology

Top Story

Computational biologist to lead precision medicine institute at Weill Cornell Medicine

Computational biologist to lead precision medicine institute at Weill Cornell Medicine
September 23, 2017

Olivier Elemento, PhD, has been appointed director of the Caryl and Israel Englander Institute for Precision Medicine at Weill Cornell Medicine.

Elemento, a computational biologist who is recognized for his expertise in the fields of computational genomics and biomedicine, will succeed Mark A. Rubin, MD, the institute’s founding director.

Charles S. Fuchs, MD
FDA approvals

FDA approves Keytruda for certain gastric cancers

September 22, 2017
The FDA today approved pembrolizumab for the treatment of patients with recurrent locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma…
Baseball star who survived melanoma ‘suffering’ from lack of sunscreen use
Video

Baseball star who survived melanoma ‘suffering’ from lack of sunscreen use

September 22, 2017
Mike Schmidt, a former member of the Philadelphia Phillies widely considered to be the greatest third baseman in Major League Baseball history, received a …
Krishnansu Tewari
In the Journals Plus

Bevacizumab extends survival in advanced cervical cancer

September 22, 2017
The addition of bevacizumab to chemotherapy continued to show significant survival benefits in women with advanced cervical cancer, according to final analysis of a…
Gurman says, ‘Our voice is their voice’ in explaining the importance of physician advocacy

Gurman says, ‘Our voice is their voice’ in explaining the importance of physician advocacy

September 22, 2017
At a time when the state of health care is in flux, it is critical that physicians engage in the national debate by telling their stories and those of their patients to…
More Headlines »
CME
Castration-resistant prostate cancer

Bridging the Gap from Knowledge to Practice in CRPC

This activity is supported by educational funding provided by AbbVie Inc.; Astellas Scientific and Medical Affairs, Inc. and Medivation; and Sanofi US.

The selection of therapy for patients with castration-resistant prostate cancer (CRPC) remains challenging. Review…
More »
Video
Meeting News
VIDEO: Gefitinib may ‘change the paradigm’ to treat lung cancer

VIDEO: Gefitinib may ‘change the paradigm’ to treat lung cancer

August 10, 2017
More »
Resource Centers
European Society for Medical Oncology Congress

European Society for Medical Oncology Congress
CME
Multiple Myeloma Patient Management Embracing New Advancements Overcoming New Challenges

Multiple Myeloma Patient Management: Embracing New Advancements, Overcoming New Challenges

Support for this activity has been provided through educational grants from Amgen; Celgene Corporation; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Oncology.

The multiple myeloma clinical landscape has evolved significantly, with not only 10 new drugs but also new staging…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement
  • Advertisement
  • Resources from Industry